Keyphrases
Maintenance Therapy
100%
Further Treatment
100%
Treatment Strategy
100%
Infliximab
100%
Inflammatory Bowel Disease
100%
Paraclinical
75%
Endoscopy
75%
Induction Therapy
75%
Adalimumab
75%
Clinical Markers
50%
Treatment Discontinuation
50%
Complex Fistula
50%
Immunosuppressive Therapy
50%
Primary Response
50%
Treatment Efficacy
50%
Therapy Treatment
25%
Disease Treatment
25%
Initial Treatment
25%
Therapy Effect
25%
MRI Scan
25%
Days of Treatment
25%
Perianal Crohn's Disease
25%
Crohn's Disease
25%
Biological Drugs
25%
Colectomy
25%
Treatment Response
25%
Fistula Repair
25%
Partial Response
25%
Fistula
25%
Treatment Failure
25%
Surgical Treatment
25%
Drug Administration
25%
High Dose
25%
Conventional Therapy
25%
Diagnostic Imaging
25%
Systemic Steroids
25%
Active Ulcerative Colitis
25%
Possible Complications
25%
Disease Manifestations
25%
Inflammatory Activity
25%
Moderate to Severe
25%
Medicine and Dentistry
Biological Therapy
100%
Infliximab
100%
Maintenance Therapy
100%
Inflammatory Bowel Disease
100%
Fistula
75%
Adalimumab
75%
Endoscopy
75%
Combination Therapy
75%
Immunosuppressive Treatment
50%
Ulcerative Colitis
50%
Crohn's Disease
50%
Ibuprofen
25%
Infusion
25%
Drug Administration
25%
Drug Megadose
25%
Magnetic Resonance Imaging
25%
Diagnostic Imaging
25%
Diseases
25%
Side Effect
25%
Treatment Response
25%
Infection
25%
Surgery
25%
Therapy Effect
25%
Colectomy
25%
Pharmacology, Toxicology and Pharmaceutical Science
Infliximab
100%
Inflammatory Bowel Disease
100%
Fistula
75%
Combination Therapy
75%
Adalimumab
75%
Immunosuppressive Agent
50%
Crohn's Disease
50%
Ulcerative Colitis
50%
Drug Administration
25%
Diseases
25%
Inflammation
25%
Infection
25%
Side Effect
25%
Ibuprofen
25%